Metabolomic analysis and mass spectrometry imaging after neonatal stroke and cell therapies in mouse brains
Abstract Ischemic brain injury provokes complex, time-dependent downstream pathways that ultimately lead to cell death. We aimed to demonstrate the levels of a wide range of metabolites in brain lysates and their on-tissue distribution following neonatal stroke and cell therapies. Postnatal day 12 m...
Guardado en:
Autores principales: | Emi Tanaka, Yuko Ogawa, Ritsuko Fujii, Tomomi Shimonaka, Yoshiaki Sato, Takashi Hamazaki, Tokiko Nagamura-Inoue, Haruo Shintaku, Masahiro Tsuji |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/642301be6d594791aaff0e5f015b232c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Serum Metabolomics of Tick-Borne Encephalitis Based on Orbitrap-Mass Spectrometry
por: Zhang M, et al.
Publicado: (2021) -
Ion identity molecular networking for mass spectrometry-based metabolomics in the GNPS environment
por: Robin Schmid, et al.
Publicado: (2021) -
Metabolic Profile of C-Prenyl Coumarins Using Mass Spectrometry-Based Metabolomics
por: Yan Cheng, et al.
Publicado: (2021) -
Sub-nanoliter metabolomics via mass spectrometry to characterize volume-limited samples
por: Yafeng Li, et al.
Publicado: (2020) -
Breath and plasma metabolomics to assess inflammation in acute stroke
por: Waqar Ahmed, et al.
Publicado: (2021)